Handelsbanken Fonder’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-5,779
Closed -$1.42M 1633
2022
Q3
$1.42M Buy
5,779
+318
+6% +$85.9K 0.01% 574
2022
Q2
$1.35M Sell
5,461
-4,129
-43% -$1.11M 0.01% 604
2022
Q1
$3.18M Sell
9,590
-848
-8% -$261K 0.02% 519
2021
Q4
$3.75M Sell
10,438
-837
-7% -$283K 0.02% 518
2021
Q3
$3.67M Buy
11,275
+21
+0.2% +$7.11K 0.02% 522
2021
Q2
$3.51M Sell
11,254
-273
-2% -$83.7K 0.02% 535
2021
Q1
$3.67M Buy
11,527
+548
+5% +$175K 0.02% 502
2020
Q4
$3.56M Buy
10,979
+702
+7% +$194K 0.02% 488
2020
Q3
$2.85M Buy
10,277
+700
+7% +$202K 0.02% 481
2020
Q2
$2.31M Buy
+9,577
New +$1.92M 0.02% 491
2019
Q3
Sell
-25,500
Closed -$6.64M 195
2019
Q2
$6.64M Sell
25,500
-6,000
-19% -$1.59M 0.12% 154
2019
Q1
$9M Buy
31,500
+13,000
+70% +$4.32M 0.17% 131
2018
Q4
$6.01M Buy
18,500
+2,000
+12% +$695K 0.12% 138
2018
Q3
$7.42M Buy
16,500
+7,000
+74% +$2.76M 0.14% 139
2018
Q2
$3.89M Sell
9,500
-8,000
-46% -$2.9M 0.08% 155
2018
Q1
$5.09M Sell
17,500
-2,500
-13% -$634K 0.1% 149
2017
Q4
$3.75M Hold
20,000
0.08% 146
2017
Q3
$3.37M Buy
20,000
+12,000
+150% +$1.81M 0.08% 148
2017
Q2
$1.15M Buy
+8,000
New +$1.08M 0.03% 157

Other funds holding ABMD

Handelsbanken Fonder's ABMD Position: Q4 2022 in Review

Handelsbanken Fonder sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 5,779 shares — an estimated $1.42M sold.

Handelsbanken Fonder first reported a position in ABMD in Q2 2017 and held it in 19 quarters. The position peaked at $9M in Q1 2019. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Handelsbanken Fonder reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Handelsbanken Fonder sold 5,779 Abiomed Inc shares in Q4 2022, an estimated $1.42M.
  • Handelsbanken Fonder first reported a position in Abiomed Inc in Q2 2017 and held it in 19 quarters.
  • Handelsbanken Fonder's Abiomed Inc position peaked at $9M in Q1 2019.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Handelsbanken Fonder's 13F filing for Q4 2022, filed 7 Feb 2023.